Adel S El-Azab, Alaa A-M Abdel-Aziz, Silvia Bua, Alessio Nocentini, Ahmed H Bakheit, Hamad M Alkahtani, Mohamed M Hefnawy, Claudiu T Supuran
In this study, The inhibitory actions of human carbonic anhydrase (CA, EC 4.2.1.1) (hCA) isoforms I, II, IX, and XII are being examined using recently synthesized substituted hydroxyl Schiff derivatives based on the quinazoline scaffold 4 - 22 . Quinazolines 2 , 3 , 4 , 5 , 7 , 10 , 15 , and 18 reduce the activity of hCA I isoform effectively to a Ki of 87.6-692.3 nM, which is nearly equivalent to or more potent than that of the standard drug AAZ (Ki, 250.0 nM). Similarly, quinazolines 2 , 3 , and 5 and quinazoline 14 effectively decrease the inhibitory activity of the hCA II isoform to a KI of 16...
December 2023: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society